Hyun Kang ,
Department of Medical Laboratory Science, College of Health Science, Dankook University, Cheonan-si, Chungnam, 330-714, Republic of Korea;
For correspondence:-
Email: hyunbio@gmail.com Tel:082-41-550-1452
Received: 26 August 2014
Accepted: 11 September 2014
Published: 15 December 2014
Citation:
Kang H,
Suppression of Lipopolysaccharide-Stimulated Neuroinflammatory Mediators by Chenopodiacea Mangrove, Suaedea maritima (L) Dumort, in BV-2 Microglial Cells. Trop J Pharm Res 2014; 13(12):1999-2004
doi:
10.4314/tjpr.v13i12.7
© 2014 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To investigate the in-vitro antioxidant and anti-neuroinflammatory effects of Suaeda maritime (L) Dumort ethyl acetate (SM-EA) extract in lipopolysaccharide (LPS)-stimulated BV-2 microglial cells.
Methods: LPS-stimulated BV- microglia were used to study the expression and production of inflammatory mediators, viz, nitric oxide (NO), inducible NO synthase (iNOS, interleukin (IL)-6) and tumor necrosis alpha (TNF-α). Antioxidant activity was measured using 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) assay. Cell viability was estimated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5- diphenyl-tetrazolium bromide (MTT) assay.
Results: SM-EA extract significantly suppressed LPS-induced production of NO (p < 0.001 at 80 and 100 μg/ml) and expression of iNOS in BV-2 cells. SM-EA also suppressed LPS-induced increase in IL-6 and TNF-α levels (p < 0.001at 100 μg/ml) in BV- cells. Further, DPPH-generated free radicals were inhibited by SM-EA extract in a concentration-dependent manner (p < 0.01 at 0.1 mg/ml and p < 0.001 at 1 mg/ml) with half maximal inhibitory concentration (IC50) of 0.42 mg/ml.
Conclusion: The findings imply that SM-EA extract can be developed as a potential therapeutic agent in regulating microglia-mediated neuroinflammatory responses observed in several neurodegenerative diseases.
Keywords: Suaedea maritime, Chenopodiaceae, Anti-oxidant, Anti-inflammatory, Microglial cells, Inducible nitric oxide synthase, Interleukin-6